CEL-SCI Corporation Reports 2009 Second Fiscal Quarter Financial Results
... of new biological and stem cell produced products. Promising preclinical studies supporting the Company's proprietary L.E.A.P.S.(TM) (Ligand epitope Antigen Presentation System) vaccine technology. The studies suggest that L.E.A.P.S. could potentially induce protection against illnesses such as swi...Tracon Pharmaceuticals to Present Clinical Stage Programs at AACR 2009
...er Date and Time: Wednesday, April 22, 2009, 8:00 AM Abstract Number: 5433 TRC093 Abstract Title: Targeting the HU177 cryptic collagen epitope with humanized antibody TRC093 functions cooperatively with anti-VEGF therapy to inhibit tumor growth Presenter: Jennifer M. Roth, PhD, Maine Medic...EpiVax Receives NIH Grant for $390,000 to Optimize HIV Vaccine Delivery
...i-DEC-205 as a stand-alone HIV antigen delivery system that obviates the dangers associated with non-specific activation of the immune system. epitope modification is an immunomodulatory approach EpiVax previously developed to reduce immunogenicity of protein therapeutics. Here, EpiVax will substitut...CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
...armacy and Dr. Dan Zimmerman, CEL-SCI's Senior Vice President of Research and Cellular Immunology, demonstrated that immunization with a LEAPS (Ligand epitope Antigen Presentation System) vaccine altered the immunological hormone (cytokine) balance toward a Th1 environment. It has been shown that a Th1 cellu...Gene Linked to Inflammatory Arthritis Also Raises Heart Risks
...or of premature death from CVD in patients with inflammatory arthritis. The researchers said that, for RA patients in particular, having the shared epitope (SE) -- a group of HLA-DRB1 alleles with kindred amino acid traits -- plus anti-cyclic citrullinated peptide (anti-CCP) antibodies and being a current...The HLA-DRB1 gene and premature death in rheumatoid arthritis
...bility and severity, as a predictor of premature death from CVD for inflammatory arthritis patients. For RA patients in particular, having the shared epitope (SE)a group of HLA-DRB1 alleles with kindred amino acid traitsplus anti-cyclic citrullinated peptide (anti-CCP) antibodies and current smoking is an e...Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
...nal, fully human, next generation monoclonal antibody that targets a unique epitope of the CD20 receptor on the surface of B-cells. Other anti-CD20 antibodies currently available or in development bind to a different epitope on the CD20 receptor. Ofatumumab is being developed under a co-development ...Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
... is a specialty biopharmaceutical company focused on the field of allergy. The company's range of allergy therapeutics utilizes its proprietary T-cell epitope desensitization technology, ToleroMune. Circassia's products offer potential major clinical benefits compared with existing therapies, and consequentl...Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
... is a specialty biopharmaceutical company focused on the field of allergy. The company's range of allergy therapeutics utilizes its proprietary T-cell epitope desensitization technology, ToleroMune. Circassia's anti-allergy products offer potential major clinical benefits compared with existing therapies, an...Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
...ions, Lansdowne Partners, Goldman Sachs and Invesco Perpetual. Circassia's lead products target allergies utilizing the company's proprietary T-cell epitope desensitization technology, ToleroMune. The company is also developing its ToleroTrans organ anti-rejection technology, which uses a similar approach ...Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
...ions, Lansdowne Partners, Goldman Sachs and Invesco Perpetual. Circassia's lead products target allergies utilizing the company's proprietary T-cell epitope desensitization technology, ToleroMune. The company is also developing its ToleroTrans organ anti-rejection technology, which uses a similar approach ...Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
...ongoing research and development activities with its L.E.A.P.S.(TM) (Ligand epitope Antigen Presentation System) technology. L.E.A.P.S.(TM) is a novel T-cell m...ic peptides. The L.E.A.P.S.(TM) constructs containing the antigenic disease epitope linked to a T-cell binding ligand (TCBL) can be manufactured by peptide syn...NIH selects LIAI for major study on allergy molecular causes and possible treatments
...able to scientists worldwide via the NIAIDs Immune epitope Database (IEDB), the worlds largest research datab...h bioinformatics along with the use of the allergy epitope information already in the IEDB. Bioinformatics u...ake advantage of that huge resource to improve our epitope identification algorithms based on that data, said...New details on how the immune system recognizes influenza
...tention." The analysis drew upon a much larger effort called the Immune epitope Database and Analysis Resources Program, which began in 2004 after NIAID aw...eys, and very little comes from humans or birds. In fact, only one antibody epitope came from a human. The LIAI researchers say more studies should be focused ...LIAI completes world's most comprehensive analysis on influenza virus data
...to date worldwide, drawing from the NIAID's Immune epitope Database, a new worldwide scientific resource that... the first time that all known antibody and T cell epitope information has been compiled in one place," said ..., but would have no way of knowing if a particular epitope had been used one time, for example by a single in...Fragment of yellow fever virus may hold key to safer vaccine
...y all homed in on one particular part of the protein coating the virus. The epitope is called E-71, signifying its address on the envelope protein. Several oth...bodies against yellow fever likely span the pairs by grabbing the essential epitope on one and the supporting amino acids on the other, ter Meulen speculates. ...Touching Molecules With Your Bare Hands
...in. One region strongly associated with inhibiting epitope presentation to killer T cells corresponded to red...latent virus. These results indicate that avoiding epitope presentation during episome maintenance is key to ...dies will have to determine the responsible MHV-68 epitope and the mechanisms that engineer immune avoidance....How A Latent Virus Eludes Immune Defenses
...in. One region strongly associated with inhibiting epitope presentation to killer T cells corresponded to red...latent virus. These results indicate that avoiding epitope presentation during episome maintenance is key to ...dies will have to determine the responsible MHV-68 epitope and the mechanisms that engineer immune avoidance....Enhanced Protein Tomography(TM) Method for Rapid Epitope Determination
STOCKHOLM, Sweden, June 5 /PRNewswire/ -- Sidec has of today introduced a new version of its Protein Tomography(TM) technology. The new developments drastically improve the analysis of therapeutic antibodies and drug targets in biological systems. (Logo: http://www.newscom.com/cgi-bin/prnh/...An Epitope Tagging Vector for Gene Expression in Mammalian Cells
An Epitope Tagging Vector for Gene Expression in Mammalian Cells Use tag-specific antibodies to study expressed genes Tanya Hosfield Quinn Lu Stratagene The pCMV-Tag1 vector is an epitope tagging vector designed for gene expression in mammalian cells. A target gene insert...CEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies
...demonstrated that vaccines utilizing its proprietary L.E.A.P.S.(TM) (Ligand epitope Antigen Presentation System) vaccine technology could potentially induce pr...thetic peptides. The L.E.A.P.S. constructs containing the antigenic disease epitope linked to an Immune / T-cell binding ligand (I/TCBL) can be manufactured by...ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results
... - Expanding EHT 202 program to other CNS indications - Initiation of epitope discovery programs for ocular disorders with Allergan - Preparing...igate a variety of ocular disease related models in order to discover novel epitope targets for the development of therapeutic antibodies. EHT/AGN 0001,...Epitomics Appoints Dr. Zhiqiang An as Chief Scientific Officer
... "RabMAb(R) is a novel class of monoclonal antibodies which possess unique biological properties, including ultra-high affinity, diversity in epitope recognition, and high target specificity. Epitomics provides me with the opportunity to expand the healthcare promises of biologics by developing RabM...Publication on 'Tregitopes' in Blood Journal of October 2008
...to generate new therapeutics for cancer and autoimmune diseases as well as new vaccines for infectious diseases such as HIV, TB, and hepatitis. T cell epitope mapping, the selection of target peptides from any protein sequence, is a powerful resource for the development of novel protein therapeutics. EpiVax ...IHC Select TE Buffer pH 9.0 [Antigen/ Epitope Retrieval Reagent], 10x from CHEMICON
Description: Request Info...PT ModuleTM Deparaffinization and Heat-Induced Epitope Retrieval Solution (10X) from Lab Vision
Description: This product is designed to deparaffinize and perform Heat Induced Antigen Retrieval (HIER) on formalin fixed paraffin-embedded tissue sections mounted on glass microscope slides. Deparffinization is accomplished by melting the paraffin at the high temperature used in HIER (over 90degrees C) along ...PT ModuleTM Deparaffinization and Heat-Induced Epitope Retrieval Solution (100X) from Lab Vision
Description: This product is designed to deparaffinize and perform Heat Induced Antigen Retrieval (HIER) on formalin fixed paraffin-embedded tissue sections mounted on glass microscope slides. Deparffinization is accomplished by melting the paraffin at the high temperature used in HIER (over 90degrees C) along ...Rabbit Anti-RFP Epitope Tag Antibody, Unconjugated from ABR-Affinity BioReagents
Description: Immunogen: Synthetic Peptide: V(22) N G H E F E I E G E G E G R(36) Storage: -20 C, Avoid Freeze/Thaw Cycles...Concentrated Epitope Retrieval Buffer-Reduced pH from Bethyl Laboratories
Description: Bethyl Laboratories Epitope Retrieval Buffer-Reduced pH will unmask antigenic sites from formaldehyde fixation and allow for subsequent immunostaining. Shelf-Life: 1 year from date of receipt...Custom Epitope Peptide Microarray from LC Sciences
Description: Microarrays designed for immunological studies, vaccine development, and biosensor development built on the flexible and powerful Paraflo microfluidic on-chip synthesis platform. These microarrays are available as part of our comprehensive Epitope Peptide Microarray Service. Custom Probe Content ...Rabbit Anti-Human PITPNB Polyclonal Antibody, Unconjugated from Atlas Antibodies
Description:...er protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein epitope Signature Tag (PrEST)....Rabbit Anti-Human SP2 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Description:... Transcription factor Sp2. [Source:Uniprot/SWISSPROT;Acc:Q02086] Antigen: Recombinant Protein epitope Signature Tag (PrEST)....Rabbit Anti-Human C1QC Polyclonal Antibody, Unconjugated from Atlas Antibodies
Description:... Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein epitope Signature Tag (PrEST)....